May 12, 2022
May 11, 2022
May 10, 2022
May 09, 2022
May 07, 2022
Dhiren Patel, PharmD, Robert Busch, MD, and Diana Issacs, PharmD, discuss recent advances in diabetes technology and their impact on patient care.
A provider toolkit with clinically relevant resources related to diagnosis and management of central precocious puberty.
Our Disease State Series was born out of the idea of providing the most practical information and resources to clinicians. In this installment, we will be focusing on thyroid disorders.
A pair of experts in the management of diabetes review the role of insulin therapy and review the approval process for biosimilars, including the FDA's approval of the first interchangeable insulin biosimilar.
May 06, 2022
Data from a study presented at the European Congress on Obesity details the effects of adherence to a vegan diet on cardiometabolic health using data obtained from randomized controlled trials assessing the effects of vegan diets as an intervention.
May 05, 2022
A 3-month trial found reducing sedentary time by just an hour per day was enough to produce statistically significant changes in biomarkers for cardiovascular risk among patients with metabolic syndrome.
May 04, 2022
Data from a pivotal trial presented at ATTD 2022 demonstrate the use of the iLet Bionic Pancreas was associated with significant improvements in HbA1c and TIR among a diverse study population of adults and children with type 1 diabetes compared with standard care.
May 03, 2022
A review of data presented at ATTD 2022 dissects what features within smartphone applications created to improve diabetes management actually contribute to improved glycemic control.
May 02, 2022
New data suggests the number of prescriptions for SGLT2 inhibitors in the US has doubled since 2015 with prescriptions for GLP-1 receptor agonists tripling during the same time period.